|
SR140 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.1372999999042E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.59199999999871E-05 |
| Normal-vs-Stage2 |
4.26370000000675E-05 |
| Normal-vs-Stage3 |
8.24939999644059E-08 |
| Normal-vs-Stage4 |
2.836100E-04 |
| Stage1-vs-Stage2 |
2.171600E-01 |
| Stage1-vs-Stage3 |
3.512200E-02 |
| Stage1-vs-Stage4 |
3.563000E-01 |
| Stage2-vs-Stage3 |
7.650600E-01 |
| Stage2-vs-Stage4 |
8.104800E-01 |
| Stage3-vs-Stage4 |
5.619600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.42430000005245E-06 |
| Normal-vs-AfricanAmerican |
7.920300E-02 |
| Normal-vs-Asian |
5.478900E-03 |
| Caucasian-vs-AfricanAmerican |
2.229800E-01 |
| Caucasian-vs-Asian |
2.893200E-01 |
| AfricanAmerican-vs-Asian |
7.037400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.30240000000026E-05 |
| Normal-vs-Female |
9.19039999991433E-07 |
| Male-vs-Female |
8.803000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.15389999999438E-05 |
| Normal-vs-Age(41-60Yrs) |
2.71200000001581E-06 |
| Normal-vs-Age(61-80Yrs) |
5.6343999999986E-05 |
| Normal-vs-Age(81-100Yrs) |
9.75539999999997E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.285600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.683200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.946400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.135200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.451800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.195800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.261500E-03 |
| Classical-VS-Follicular |
5.342100E-02 |
| Classical-VS-Other |
8.373800E-01 |
| Classical-VS-Normal |
7.93890000000408E-05 |
| Tall-VS-Follicular |
2.914400E-01 |
| Tall-VS-Other |
2.490600E-01 |
| Tall-VS-Normal |
4.4400999998917E-07 |
| Follicular-VS-Other |
6.598600E-01 |
| Follicular-VS-Normal |
2.4876000000007E-05 |
| Other-VS-Normal |
1.145610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.42530000002417E-06 |
| Normal-vs-N1 |
9.223500E-03 |
| N0-vs-N1 |
2.261000E-01 |
|
|
